phenylalanine and Lower Extremity Weakness, Spastic

phenylalanine has been researched along with Lower Extremity Weakness, Spastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blau, N; Casaer, P; Goriounov, D; Hedrich, K; Klein, C; Legius, E; Matthijs, G; Møller, LB; Romstad, A; Steyaert, J; Theys, P; Van Hove, JL; Wevers, R1
Jinnah, HA; Kasim, S; Moo, LR; Zschocke, J1

Other Studies

2 other study(ies) available for phenylalanine and Lower Extremity Weakness, Spastic

ArticleYear
Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency.
    Journal of neurology, neurosurgery, and psychiatry, 2006, Volume: 77, Issue:1

    Topics: Adolescent; Adult; Circadian Rhythm; Dystonia; Female; Fibroblasts; Gene Expression; GTP Cyclohydrolase; Humans; Lower Extremity; Male; Middle Aged; Paraparesis, Spastic; Parkinsonian Disorders; Pedigree; Phenotype; Phenylalanine; Polymerase Chain Reaction; Reflex, Abnormal; Syndrome; Tendinopathy; Tremor

2006
Phenylketonuria presenting in adulthood as progressive spastic paraparesis with dementia.
    Journal of neurology, neurosurgery, and psychiatry, 2001, Volume: 71, Issue:6

    Topics: Age of Onset; Cognition; Dementia; Diagnosis, Differential; Diet, Protein-Restricted; Disease Progression; Female; Gait; Genotype; Humans; Magnetic Resonance Imaging; Middle Aged; Mutation; Neuropsychological Tests; Paraparesis, Spastic; Phenotype; Phenylalanine; Phenylketonurias; Treatment Outcome

2001